Kratos (KTOS) VP Reports Multiple 09/15/2025 Share Sales Under 10b5-1
Rhea-AI Filing Summary
Maria Cervantes de Burgreen, Vice President and Corporate Controller of Kratos Defense & Security Solutions (KTOS), reported multiple open-market sales of the issuer's common stock on 09/15/2025 executed under a pre-existing 10b5-1 trading plan adopted June 16, 2025. The filings show four separate sale entries: 500 shares at a weighted-average price of $68.664, 4,088 shares at $69.4994, 1,576 shares at $70.8329, and 100 shares at $71.24. Beneficial ownership reported declined across these transactions from 59,373 to 53,609 shares. The disclosure notes 6,422 shares held via the company ESPP and approximately 6,689 shares held through the company 401(k) plan. The Form 4 was signed by Attorney-In-Fact Eva Yee on behalf of the reporting person on 09/17/2025.
Positive
- Sales executed under a pre-established 10b5-1 trading plan, indicating a structured and pre-scheduled disposition strategy
- Detailed price ranges and weighted-average prices provided in footnotes, with offer to supply per-trade details on request
- Disclosure of ESPP and 401(k) holdings adds transparency to the reporting person's total beneficial ownership
Negative
- Beneficial ownership decreased by 5,764 shares from 59,373 to 53,609 following the reported sales
Insights
TL;DR: Insider executed planned sales under a 10b5-1; ownership decreased modestly by 5,764 shares.
The transactions were routine, executed pursuant to a documented 10b5-1 plan adopted June 16, 2025, which reduces information asymmetry about timing intent. The sale schedule shows four tranches on a single date with weighted-average prices between $68.66 and $71.24, producing a stepwise decline in beneficial ownership from 59,373 to 53,609 shares. No derivative transactions or additional compensatory grants are reported. From an investor-impact perspective, these appear administrative rather than signaling new company-specific inside information.
TL;DR: Disclosure follows standard governance practice; sales documented under 10b5-1 improve compliance transparency.
The Form 4 clearly states the 10b5-1 plan adoption date and provides weighted-average price ranges for multi-trade executions, with commitments to provide detailed trade-level information on request. The filer identified her role as VP & Corporate Controller and disclosed holdings in the ESPP and 401(k), enhancing clarity about direct ownership. There are no indications of amendments, option exercises, or indirect holdings beyond retirement/ESPP accounts in this filing.
FAQ
What insider transactions did KTOS VP & Corporate Controller report on Form 4?
Were the KTOS insider sales part of a 10b5-1 plan?
How did these transactions change the insider's beneficial ownership of KTOS?
Does the Form 4 disclose indirect holdings for the KTOS reporting person?
Who signed the Form 4 for the KTOS reporting person and when?